Addressing Health Disparities Among Oklahoma Minority and Rural Communities Through Clinical Research Education and Career Development


Apply NowPhase I  Application deadline: May 1,2018

Apply NowPhase II Application deadline: January 31,2018
Principal Investigators:  Julie Stoner, PhD and Courtney Houchen, MD

Program Goal: 

Facilitate the education of participants from diverse backgrounds underrepresented in biomedical research to pursue clinical research, translational and/or patient-oriented research, or population health research particularly on diseases that disproportionately impact minority, rural, and health disparity populations.

 

Learn more about the program:


 

Eligible Program Participants

  • Post-doctoral fellows and junior faculty, within seven years of their first faculty appointment, who aim to become productive, independent clinical or population health research investigators in the areas of minority health, rural health and health disparities research.
  • Member of diverse background underrepresented in biomedical research  Racial and ethnic groups that have been shown by the National Science Foundation to be underrepresented  Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, and Native Hawaiians and other Pacific Islanders  Individuals with disabilities
  • Must be U.S. citizens or permanent residents.
  • Preference given to applicants with a clinical doctoral degree, including, but not limited to, an M.D., D.D.S., D.O., O.D., N.D., Pharm.D., Doctorate of Nursing, Doctorate of Physical Therapy, Doctorate of Occupational Therapy, Doctorate of Rehabilitation, or D.V.M.  Individuals with a Ph.D. may also apply - Ph.D. with clinical responsibilities, Ph.D. with a focus on clinical or population health research 
  • Phase II applicants must have completed Phase I or equivalent training and must meet the NIH definition of Early Stage Investigator  Early Stage Investigator: An Early Stage Investigator is a new investigator who has completed his or her terminal research degree or medical residency—whichever date is later—within the past 10 years and has not yet competed successfully for a substantial, competing NIH research grant.

Program Training Phases


Phase I   Phase I trainees will receive 50% salary support to complete the MS in Clinical and Translational Science degree program, including completion of a thesis research project. Trainees will be mentored by an interdisciplinary team of faculty researchers.

  • Didactic program courses for skill development in clinical and population health research
  • Earn a Master of Science degree in Clinical and Translational Science
  • Complete a thesis research project focused on health issues in underserved populations
  • Funding for up to two years
  • Application deadline: May 1, 11:59 PM, for Fall program matriculation


Phase II  Scholars will receive 75% salary support. A three-year plan will be developed with guidance from a mentoring team that will include training in scientific writing and grant writing as well as training in Responsible Conduct of Research. The development plan will include a series of research projects that will result in research products necessary to support a career development award or R series award application in the second or third year of the appointment.

  • Mentored research experience
  • Funding for up to three years
  •  Application deadline: January 31, 11:59 PM, for March 1 start date

Funding


Phase I  Funding (annual funding for two years)

• 50% protected time (salary+fringe)

• Tuition and fees (up to 33 credit hours over the 2-year program)

• $1250 travel funds • $5000 research funds

• $2500 mentor’s research expenses Up to two trainees will be funded at any one time in the program.


Phase II  Funding (annual funding for up to three years) • 75% protected time (salary+fringe)

• $1250 travel funds

• $5000 research funds

• $2500 mentor’s research expenses

Up to two Phase II trainees will be funded at any one time in the program.


Application Materials


Phase I  Program applications are due May 1 at 11:59 PM for a Fall semester matriculation. The application will include an official transcript from all prior universities attended, a completed OUHSC Graduate College application, three letters of recommendation, one-page statement of career goals indicating how the MS in CTS will advance the career of the applicant, a two-page research proposal for the thesis project, the primary mentor’s NIH biosketch, and a current CV for the applicant.

  • Initiate a Phase I program application here:

https://redcap.ouhsc.edu/redcap/surveys/?s=CKD3C9MDW9



Phase II  Program applications are due January 31 at 11:59 PM. The application will include a summary of career goals and research interests along with a research proposal and planned timeline for a career development or R-series award application. In addition, a letter of support must be included from the proposed primary mentor and the department chair or section chief agreeing to the time commitment required for the CRECD program.

The applications will be reviewed by the CRECD Advisory Committee. The top four applicants will be invited to deliver a 30-minute oral presentation of their research goals, interests, and career development plans.

  • Initiate a Phase II program application here:

https://redcap.ouhsc.edu/redcap/surveys/?s=LHEA37X9EN


Contact Us

For additional information, please contact:

Julie Stoner, PhD Program Co-Director Phone: (405) 271-2229 x 49480 Email: julie-stoner@ouhsc.edu

Carla Shackelford Program Coordinator 405-271-8001 Ext. 48833 (Direct Line) Email: carla-shackelford@ouhsc.edu


Acknowledgement:  This education and career development program is supported by the National Institute on Minority Health and Health Disparities and National Institute of General Medical Sciences of the National Institutes of Health under Award Numbers R25MD011564 and 1 U54GM104938. The content is solely the responsibility of the program directors and does not necessarily represent the official views of the National Institutes of Health.